Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Extended tirzepatide use over 2+ years is well-tolerated in clinical trials, with early side effects like nausea typically diminishing over weeks
Clinical trials have demonstrated hemoglobin A1c reductions of approximately 2% in diabetes patients, with weight loss ranging from 7-11% in diabetes trials (SURPASS) and 15-21% in obesity trials (SURMOUNT), depending on the dose administered and patient population
Most patients self-administer their weekly injections at home after completing in-office training
Drawing gets the right amount into your syringe
US$ 26.45
US$ 23.10
US$ 25.63
US$ 25.16
US$ 28.66
/assets/production/practices/728823589dde9ee26538014746af0608984170b3/images/2742608.jpg)
US$ 21.23
US$ 22.80
US$ 20.82
US$ 25.97
US$ 27.69
US$ 20.28
